Define your goals clearly
Retatrutide Phase 2 (Jastreboff et al., NEJM 2023) reported 24.2% weight loss at 48 weeks at 12 mg
Indeed, a significantly lower glutathione-S-transferase (GST) enzyme activity and significantly high MDA levels have been shown in the cumulus cells of poor responders compared to high responders (220)
Hydrafinil Reclassification: Hydrafinil is now classified as a non-specified stimulant
SUSTAIN FORTE: Ozempic injection 1 mg vs 2 mg 1,4 Study design: 40-week, randomized, active-controlled, parallel-group, double-blind, phase 3B efficacy and safety trial of Ozempic injection 2 mg vs Ozempic injection 1 mg in patients with T2D in need of treatment intensification
(3) Lysis: Cell samples were lysed at 1x106 cell number with 100L of lysis solution, and lysed on ice for 30min (or lysed on ice for 5min and sonicated on ice bath for 20s)